trospium chloride has been researched along with Bladder, Overactive in 56 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 18 (32.14) | 29.6817 |
| 2010's | 34 (60.71) | 24.3611 |
| 2020's | 4 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Andreev, MN; Darenkov, SP; Korshunov, DM; Korshunov, MN; Korshunova, ES; Pyatnitskaya, TM; Suponeva, NA | 1 |
| Bhide, AA; Digesu, GA; Swift, S | 1 |
| Kulchavenya, EV; Shevchenko, SY | 1 |
| Araklitis, G; Cardozo, L; Robinson, D | 1 |
| Coban, S; Demirbas, M; Demirci, H; Emul, A; Guzelsoy, M; Parmak Yener, N; Turkoglu, AR | 1 |
| Abdelfattah, G; Abulseoud, A; Hassouna, M; Ibrahim, I; Moussa, A; Saba, E | 1 |
| Kaufmann, A | 1 |
| Aboulhoda, BE; Ali, EN | 1 |
| Iatsyna, O; Kostyev, F; Vernygorodskyi, S | 1 |
| Bödeker, RH; Ivchenko, A; Neumeister, C; Wiedemann, A | 1 |
| Cetinel, B; Dincer, M; Gultekin, MH; Guzelsoy, M; Onal, B; Turegun, FA | 1 |
| Almeida, FG; Bernardo, WM; Sacomani, CAR; Silvinato, A | 1 |
| Hart, WM; Nazir, J | 1 |
| Benbouzid, R; Enjalbert, M; Hadiji, N; Leblond, C; Mieusset, R; Previnaire, JG; Robain, G; Soler, JM | 1 |
| Kosilov, KV; Kosilova, LV; Krasnykh, MA; Loparev, SA | 1 |
| Ivanovskaya, M; Kosilov, K; Kosilova, L; Loparev, S | 1 |
| Ivanovskaya, MA; Kosilov, KV; Kosilova, LV; Loparev, SA | 1 |
| Ariogul, S; Cankurtaran, E; Cankurtaran, M; Ergen, A; Esin, E; Halil, M; Kuyumcu, ME; Ozcan, M; Ulger, Z; Yavuz, BB; Yeşil, Y | 1 |
| Fahmy, A; Mahfouz, W; Mokhless, I; Rhashad, H; Youssif, M | 1 |
| Kosilov, K; Kuzina, I; Lobodenko, A; Loparev, S; Shakirova, O; Zhuravskaya, N | 1 |
| Efremov, NS; Krivoborodov, GG; Shkolnikov, ME; Tur, EI | 1 |
| MacDiarmid, S; Malhotra, BK; Sandage, BW | 1 |
| Oefelein, MG; Staskin, DR | 1 |
| Brostrøm, S; Hallas, J | 1 |
| Biastre, K; Burnakis, T | 1 |
| Gavrilova, O; Geyer, J; Petzinger, E | 1 |
| Cardozo, L; Staskin, DR | 1 |
| Chancellor, MB; Oefelein, MG; Vasavada, S | 1 |
| Appell, RA; Dmochowski, RR; Sand, PK; Staskin, DR; Zinner, NR | 1 |
| Dmochowski, RR; Rosenberg, MT; Sand, PK; Staskin, DR; Zinner, NR | 1 |
| Akkoc, Y; Karapolat, H; Ozdedeli, S | 1 |
| Bhashi, K; Goldman, HB; Kay, G; Ling, J; Oefelein, MG; Staskin, D; Tannenbaum, C | 2 |
| Ellsworth, PI; Johnson Ii, TM; Oefelein, MG; Rovner, ES; Sand, PK; Staskin, DR | 1 |
| Bödeker, RH; Madersbacher, H; Neumeister, C; Zellner, M | 1 |
| Chapple, C | 1 |
| Akbayrak, T; Beksaç, S; Kaya, S | 1 |
| Ellsworth, PI; Ginsberg, DA; MacDiarmid, SA; Oefelein, MG; Sussman, DO | 1 |
| Ellsworth, PI; Ginsberg, DA; Oefelein, MG | 1 |
| Oefelein, MG; Rovner, ES; Sand, PK; Watanabe, JH | 1 |
| Dmochowski, RR; Oefelein, MG; Sand, PK; Siami, PF; Staskin, DR; Zinner, NR | 1 |
| Schröder, A; Thüroff, JW | 1 |
| Busby-Whitehead, J; Connolly, A; Crane, AK; Dumond, JB; Geller, EJ; Jannelli, ML; Khandelwal, CM; Matthews, CA; Parnell, BA; Robinson, BL; Wells, EC | 1 |
| Groves, R; Hautumm, B; Notz, HJ; Odenthal, KP; Werdier, D | 1 |
| Dede, FS; Dede, H; Dolen, İ; Sivaslioglu, AA | 1 |
| Harnett, MD; MacLean, L; Sandage, BW; Schwiderski, U; Shipley, J | 1 |
| Madersbacher, H; Rovner, E | 1 |
| Staskin, DR | 1 |
| Hegde, SS; Michel, MC | 1 |
| Bödeker, RH; Del Popolo, G; Di Benedetto, P; Haselmann, J; Madersbacher, H; Menarini, M; Schwantes, U | 1 |
| Colaço, J; Gonçalves, V; Metello, J; Nogueira, B; Retto, H; Torgal, M; Vieira, A | 1 |
| Chancellor, MB; de Miguel, F | 1 |
| Dmochowski, R; Sand, P; Staskin, D; Zinner, N | 1 |
| Dmochowski, RR; Sand, PK; Staskin, DR; Zinner, NR | 1 |
| Allen, ZA; Bittner, N; Brammer, S; Butler, WM; Galbreath, RW; Merrick, GS; Niehaus, A; Wallner, KE | 1 |
| Culley, EJ; Thomas, L | 1 |
11 review(s) available for trospium chloride and Bladder, Overactive
| Article | Year |
|---|---|
Cognitive Effects of Anticholinergic Load in Women with Overactive Bladder.
Topics: Acetanilides; Aged; Behavior Therapy; Benzilates; Blood-Brain Barrier; Cholinergic Antagonists; Cognitive Dysfunction; Female; Humans; Muscarinic Antagonists; Nortropanes; Thiazoles; Urinary Bladder, Overactive | 2020 |
[Urodynamic studies prior to urinary incontinence surgery : What is useful?]
Topics: Aged; Benzilates; Combined Modality Therapy; Diagnosis, Differential; Female; Guideline Adherence; Humans; Male; Nortropanes; Postoperative Complications; Prostatectomy; Risk Factors; Suburethral Slings; Urinary Bladder; Urinary Bladder, Overactive; Urinary Incontinence; Urinary Incontinence, Stress; Urodynamics; Video Recording | 2017 |
Trospium chloride treatment of overactive bladder.
Topics: Animals; Benzilates; Clinical Trials as Topic; Contraindications; Drug Interactions; Humans; Muscarinic Antagonists; Nortropanes; Urinary Bladder, Overactive | 2009 |
New once-daily formulation for trospium in overactive bladder.
Topics: Benzilates; Drug Administration Schedule; Humans; Meta-Analysis as Topic; Muscarinic Antagonists; Nortropanes; Randomized Controlled Trials as Topic; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics | 2010 |
New strategies for medical management of overactive bladder in children.
Topics: Benzhydryl Compounds; Benzilates; Botulinum Toxins; Child; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Quinuclidines; Receptors, Muscarinic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urination | 2010 |
Study of the population pharmacokinetic characteristics of once-daily trospium chloride 60 mg extended-release capsules in patients with overactive bladder and in healthy subjects.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Area Under Curve; Benzilates; Body Surface Area; Case-Control Studies; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Models, Biological; Muscarinic Antagonists; Nonlinear Dynamics; Nortropanes; Time Factors; Urinary Bladder, Overactive; Young Adult | 2013 |
Trospium chloride: the European experience.
Topics: Administration, Oral; Adult; Aged; Benzilates; Child; Europe; Female; Humans; Middle Aged; Muscarinic Antagonists; Nortropanes; Randomized Controlled Trials as Topic; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Urinary Bladder; Urinary Bladder, Overactive | 2006 |
Trospium chloride: Distinct among other anticholinergic agents available for the treatment of overactive bladder.
Topics: Benzilates; Cholinergic Antagonists; Clinical Trials as Topic; Humans; Nortropanes; Urinary Bladder, Overactive | 2006 |
Treatment of the overactive bladder syndrome with muscarinic receptor antagonists: a matter of metabolites?
Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Parasympatholytics; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive | 2006 |
Treatment of overactive bladder: selective use of anticholinergic agents with low drug-drug interaction potential.
Topics: Benzhydryl Compounds; Benzilates; Cholinergic Antagonists; Cresols; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive | 2007 |
Overactive bladder disease: the urge for better therapies.
Topics: Benzhydryl Compounds; Benzilates; Cresols; Delayed-Action Preparations; Female; Humans; Male; Muscarinic Antagonists; Nortropanes; Parasympatholytics; Patient Compliance; Phenylpropanolamine; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive | 2008 |
25 trial(s) available for trospium chloride and Bladder, Overactive
| Article | Year |
|---|---|
Effect of trospium chloride therapy on intraocular pressure and tear secretion in overactive bladder patients.
Topics: Adult; Aged; Benzilates; Female; Humans; Intraocular Pressure; Middle Aged; Nortropanes; Tears; Urinary Bladder, Overactive; Urological Agents; Young Adult | 2017 |
Transcutaneous posterior tibial nerve electrostimulation with low dose trospium chloride: Could it be used as a second line treatment of overactive bladder in females.
Topics: Adult; Benzilates; Combined Modality Therapy; Double-Blind Method; Female; Humans; Middle Aged; Nortropanes; Parasympatholytics; Quality of Life; Tibial Nerve; Transcutaneous Electric Nerve Stimulation; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urodynamics | 2018 |
Which antimuscarinic agents used in the treatment of overactive bladder increase heart rate? a prospective randomized clinical trial.
Topics: Adult; Aged; Benzhydryl Compounds; Benzilates; Benzofurans; Blood Pressure; Female; Heart Rate; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Nortropanes; Prospective Studies; Pyrrolidines; Solifenacin Succinate; Tolterodine Tartrate; Urinary Bladder, Overactive | 2019 |
[Treatment of overactive bladder in older women increased doses of antimuscarinic drugs safe and effective alternative to existing methods].
Topics: Aged; Benzhydryl Compounds; Benzilates; Cresols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Drug Synergism; Drug Therapy, Combination; Female; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urodynamics | 2014 |
Comparative effectiveness of combined low- and standard-dose trospium and solifenacin for moderate overactive bladder symptoms in elderly men and women.
Topics: Age Factors; Aged; Benzilates; Drug Therapy, Combination; Female; Humans; Male; Muscarinic Antagonists; Nortropanes; Quinuclidines; Russia; Severity of Illness Index; Sex Factors; Solifenacin Succinate; Tetrahydroisoquinolines; Time Factors; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urodynamics; Urological Agents | 2014 |
The effective tool for self-assessment of adherence to treatment in patients with benign prostatic obstruction and overactive bladder symptoms.
Topics: Aged; Benzilates; Diagnostic Self Evaluation; Drug Therapy, Combination; Humans; Male; Medication Adherence; Middle Aged; Muscarinic Antagonists; Nortropanes; Prostatic Hyperplasia; Self-Assessment; Solifenacin Succinate; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urinary Bladder, Overactive | 2017 |
Baseline incontinence severity is predictive of the percentage of patients continent after receiving once-daily trospium chloride extended release.
Topics: Benzilates; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nortropanes; Parasympatholytics; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence | 2009 |
Obesity is associated with a more severe overactive bladder disease state that is effectively treated with once-daily administration of trospium chloride extended release.
Topics: Adult; Aged; Aged, 80 and over; Benzilates; Body Mass Index; Body Weight; Double-Blind Method; Female; Humans; Middle Aged; Nortropanes; Obesity; Overweight; Parasympatholytics; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence | 2010 |
Trospium chloride extended release is effective and well tolerated in women with overactive bladder syndrome.
Topics: Benzilates; Double-Blind Method; Female; Humans; Middle Aged; Nortropanes; Parasympatholytics; Urinary Bladder, Overactive | 2009 |
Trospium chloride once-daily extended release is effective and well tolerated for the treatment of overactive bladder syndrome: an integrated analysis of two randomised, phase III trials.
Topics: Benzilates; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Nortropanes; Treatment Outcome; Urinary Bladder, Overactive | 2009 |
Comparison of intravaginal electrical stimulation and trospium hydrochloride in women with overactive bladder syndrome: a randomized controlled study.
Topics: Adult; Aged; Benzilates; Electric Stimulation Therapy; Female; Humans; Middle Aged; Nortropanes; Parasympatholytics; Patient Satisfaction; Prospective Studies; Quality of Life; Severity of Illness Index; Single-Blind Method; Urinary Bladder, Overactive; Urinary Incontinence; Urodynamics | 2010 |
Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder.
Topics: Aged; Benzilates; Central Nervous System; Female; Humans; Male; Memory; Memory Disorders; Muscarinic Antagonists; Neuropsychological Tests; Nortropanes; Urinary Bladder, Overactive | 2010 |
Trospium chloride once-daily extended release is efficacious and tolerated in elderly subjects (aged ≥ 75 years) with overactive bladder syndrome.
Topics: Aged; Aged, 80 and over; Benzilates; Delayed-Action Preparations; Epidemiologic Methods; Female; Humans; Male; Muscarinic Antagonists; Nortropanes; Patient Satisfaction; Quality of Life; Treatment Outcome; Urinary Bladder, Overactive | 2011 |
Dose escalation improves therapeutic outcome: post hoc analysis of data from a 12-week, multicentre, double-blind, parallel-group trial of trospium chloride in patients with urinary urge incontinence.
Topics: Adolescent; Adult; Aged; Benzilates; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Nortropanes; Time Factors; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Xerostomia; Young Adult | 2010 |
Trospium chloride is undetectable in the older human central nervous system.
Topics: Aged; Benzilates; Delayed-Action Preparations; Humans; Learning; Mental Recall; Muscarinic Antagonists; Neuropsychological Tests; Nortropanes; Urinary Bladder, Overactive | 2010 |
Comparison of different treatment protocols in the treatment of idiopathic detrusor overactivity: a randomized controlled trial.
Topics: Benzilates; Combined Modality Therapy; Electric Stimulation Therapy; Electromyography; Exercise Therapy; Female; Humans; Medical Records; Middle Aged; Muscarinic Antagonists; Nortropanes; Pelvic Floor; Prospective Studies; Quality of Life; Turkey; Urinary Bladder, Overactive | 2011 |
Safety and efficacy of once-daily trospium chloride extended-release in male patients with overactive bladder.
Topics: Adult; Aged; Aged, 80 and over; Benzilates; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Humans; Male; Middle Aged; Nortropanes; Parasympatholytics; Safety; Urinary Bladder, Overactive | 2011 |
Once-daily administration of trospium chloride extended release provides 24-hr coverage of nocturnal and diurnal symptoms of overactive bladder: an integrated analysis of two phase III trials.
Topics: Benzilates; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Nortropanes; Parasympatholytics; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence | 2011 |
Once-daily trospium chloride 60 mg extended release in subjects with overactive bladder syndrome who use multiple concomitant medications: Post hoc analysis of pooled data from two randomized, placebo-controlled trials.
Topics: Benzilates; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Female; Humans; Male; Middle Aged; Multivariate Analysis; Nortropanes; Placebos; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge | 2011 |
[Trospium chloride once daily for overactive bladder syndrome: results of a multicenter observational study].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzilates; Germany; Humans; Nortropanes; Parasympatholytics; Prevalence; Syndrome; Treatment Outcome; Urinary Bladder, Overactive; Young Adult | 2013 |
What is the success of drug treatment in urge urinary incontinence? What should be measured?
Topics: Adult; Benzhydryl Compounds; Benzilates; Cresols; Female; Humans; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urodynamics | 2013 |
Trospium chloride in patients with neurogenic detrusor overactivity: is dose titration of benefit to the patients?
Topics: Administration, Oral; Adult; Benzilates; Constipation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Muscle Hypertonia; Nortropanes; Parasympatholytics; Patient Compliance; Patient Dropouts; Tablets; Time Factors; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urinary Incontinence; Urodynamics; Vision Disorders | 2006 |
Comparison of the efficacy and tolerability of solifenacin succinate with or without previous use of trospium chloride.
Topics: Aged; Analgesics; Benzilates; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Middle Aged; Muscarinic Antagonists; Nortropanes; Prospective Studies; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Tetrahydroisoquinolines; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence | 2007 |
Once daily trospium chloride is effective and well tolerated for the treatment of overactive bladder: results from a multicenter phase III trial.
Topics: Benzilates; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nortropanes; Parasympatholytics; Urinary Bladder, Overactive; Urination | 2007 |
Trospium 60 mg once daily (QD) for overactive bladder syndrome: results from a placebo-controlled interventional study.
Topics: Benzilates; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nortropanes; Prospective Studies; Urinary Bladder, Overactive | 2008 |
20 other study(ies) available for trospium chloride and Bladder, Overactive
| Article | Year |
|---|---|
[Long-term safety and efficacy of trospium chloride for the treatment of neurogenic overactive bladder due to Parkinson's disease is there an effect on cognitive status?]
Topics: Benzilates; Humans; Middle Aged; Nortropanes; Parkinson Disease; Quality of Life; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive; Urinary Incontinence | 2022 |
Overactive bladder medication - do we need to revisit trospium chloride for our elderly patients?
Topics: Aged; Benzilates; Humans; Muscarinic Antagonists; Nortropanes; Urinary Bladder, Overactive | 2023 |
[Impact of the SARS-CV-2 virus on the urinary bladder].
Topics: COVID-19; Humans; Retrospective Studies; SARS-CoV-2; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urinary Incontinence | 2023 |
Evaluating the effect of three newly approved overactive bladder syndrome treating agents on parotid and submandibular salivary glands: Modulation of CXCL10 expression.
Topics: Animals; Benzilates; Benzofurans; Chemokine CXCL10; Immunohistochemistry; Male; Nortropanes; Parotid Gland; Polymerase Chain Reaction; Pyrrolidines; Rats; Rats, Sprague-Dawley; Reference Standards; Salivation; Solifenacin Succinate; Staining and Labeling; Submandibular Gland; Urinary Bladder, Overactive | 2018 |
MORPHOLOGICAL ASSESSMENT OF NO-SYNTHASE DISTRIBUTION IN OVERACTIVE BLADDER AND STRESS URINE INCONTINENCE IN ANIMAL MODELS ADMINISTERED WITH EXPERIMENTAL PHARMACOCORRECTION REGIMENS.
Topics: Acetanilides; Animals; Benzilates; Drug Therapy, Combination; Estradiol; Female; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nortropanes; Quercetin; Rats; Testosterone; Thiazoles; Urinary Bladder; Urinary Bladder, Overactive; Urinary Incontinence, Stress | 2018 |
Anticholinergic burden and comorbidities in patients attending treatment with trospium chloride for overactive bladder in a real-life setting: results of a prospective non-interventional study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Benzilates; Comorbidity; Female; Humans; Male; Muscarinic Antagonists; Nortropanes; Patient Satisfaction; Prospective Studies; Tablets; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents | 2018 |
Overactive bladder - pharmacological treatment.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Antidepressive Agents; Benzilates; Benzofurans; Brazil; Clinical Decision-Making; Drug Therapy, Combination; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Pyrrolidines; Solifenacin Succinate; Thiazoles; Tolterodine Tartrate; Urinary Bladder, Overactive | 2019 |
The cost-effectiveness of solifenacin vs. trospium in the treatment of patients with overactive bladder in the German National Health Service.
Topics: Benzilates; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Germany; Health Services; Humans; Medication Adherence; Models, Economic; National Health Programs; Nortropanes; Quality-Adjusted Life Years; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; United Kingdom; Urinary Bladder, Overactive; Urological Agents | 2014 |
Are oxybutynin and trospium efficacious in the treatment of detrusor overactivity in spinal cord injury patients?
Topics: Adult; Benzilates; Female; Humans; Male; Mandelic Acids; Nortropanes; Retrospective Studies; Spinal Cord Injuries; Time Factors; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics; Urological Agents | 2014 |
Additional correction of OAB symptoms by two anti-muscarinics for men over 50 years old with residual symptoms of moderate prostatic obstruction after treatment with Tamsulosin.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Benzilates; Drug Therapy, Combination; Humans; Male; Middle Aged; Muscarinic Antagonists; Nortropanes; Prostatic Hyperplasia; Solifenacin Succinate; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive | 2015 |
Influence of antimuscarinic therapy on cognitive functions and quality of life in geriatric patients treated for overactive bladder.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Benzhydryl Compounds; Benzilates; Benzofurans; Cognition Disorders; Cresols; Depression; Female; Follow-Up Studies; Geriatric Assessment; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive | 2015 |
Combined low-dose antimuscarinics for refractory detrusor overactivity in children.
Topics: Benzilates; Child; Drug Therapy, Combination; Female; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Prospective Studies; Urinary Bladder, Overactive | 2016 |
[High doses of trospium chloride in patients with idiopathic overactive bladder. Data of large-scale, multicenter observational program Resource].
Topics: Benzilates; Cholinergic Antagonists; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Nortropanes; Quality of Life; Urinary Bladder, Overactive | 2016 |
The effects of reformulation: improved therapeutic index.
Topics: Benzhydryl Compounds; Benzilates; Chemistry, Pharmaceutical; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive | 2008 |
Re: Giacomo Novara, Antonio Galfano, Silvia Secco, et al. A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder. Eur Urol 2008;54:740-64.
Topics: Benzilates; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Meta-Analysis as Topic; Muscarinic Antagonists; Nortropanes; Quality of Life; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; Urinary Bladder, Overactive | 2009 |
Persistence of antimuscarinic drug use.
Topics: Aged; Benzilates; Databases, Factual; Denmark; Drug Administration Schedule; Drug Prescriptions; Drug Utilization; Female; Follow-Up Studies; Humans; Male; Muscarinic Antagonists; Nortropanes; Patient Compliance; Quality of Life; Urinary Bladder, Overactive | 2009 |
The role of p-glycoprotein in limiting brain penetration of the peripherally acting anticholinergic overactive bladder drug trospium chloride.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzilates; Biological Transport; Blood-Brain Barrier; Brain; Carbon Radioisotopes; Glycoproteins; Humans; Intestine, Small; Male; Metabolic Clearance Rate; Mice; Mice, Knockout; Nortropanes; Tissue Distribution; Urinary Bladder, Overactive | 2009 |
Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms.
Topics: Aged; Benzilates; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Evidence-Based Medicine; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Nortropanes; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urodynamics | 2011 |
Effect of anticholinergic use for the treatment of overactive bladder on cognitive function in postmenopausal women.
Topics: Aged; Attention; Benzilates; Cholinergic Antagonists; Cognition; Cohort Studies; Female; Humans; Medication Adherence; Memory; Middle Aged; Neuropsychological Tests; Nortropanes; Postmenopause; Prospective Studies; Urinary Bladder; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Verbal Learning | 2012 |
Role of trospium chloride in brachytherapy-related detrusor overactivity.
Topics: Aged; Benzilates; Brachytherapy; Humans; Male; Nortropanes; Prostatic Neoplasms; Urinary Bladder, Overactive | 2008 |